Mirum Pharmaceuticals (MIRM) Treasury Shares (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Treasury Shares of $487498.0 for Q1 2026, up 37.81% year-over-year from $353743.0 in Q1 2025, and up 37.81% quarter-over-quarter from $353743.0 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Treasury Shares (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Treasury Shares history runs 9 years deep, the most recent figure standing at $487498.0 for Q1 2026.
- In Q1 2026, Treasury Shares rose 37.81% year-over-year to $487498.0; the TTM figure through Mar 2026 stood at $487498.0 (up 37.81% YoY), while the FY2025 annual figure was $353743.0, up 24.14% from the prior year.
- Treasury Shares for Q1 2026 stood at $487498.0, up from $353743.0 in the prior quarter.
- The five-year high for Treasury Shares was $487498.0 in Q1 2026, with the low at $22270.0 in Q3 2022.
- The 5-year median for Treasury Shares is $289862.5 (2024), against an average of $251279.2.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares tumbled 85.71% in 2022, then surged 120.92% in 2024.
- Mirum Pharmaceuticals' Treasury Shares stood at $22270.0 in 2022, then surged by 563.83% to $147835.0 in 2023, then jumped by 92.75% to $284955.0 in 2024, then climbed by 24.14% to $353743.0 in 2025, then surged by 37.81% to $487498.0 in 2026.
- Business Quant data shows MIRM's Treasury Shares at $487498.0 in Q1 2026, $353743.0 in Q4 2025, and $353743.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 482,528.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 482,528.00 |
| Jun 30, 2026 | 482,528.00 |
| Mar 31, 2026 | 487,498.00 |
| Mar 31, 2026 | 487,498.00 |
| Dec 31, 2025 | 353,743.00 |
| Dec 31, 2025 | 353,743.00 |
| Sep 30, 2025 | 353,743.00 |
| Sep 30, 2025 | 353,743.00 |
| Jun 30, 2025 | 353,743.00 |
| Jun 30, 2025 | 353,743.00 |
| Mar 31, 2025 | 353,743.00 |
| Mar 31, 2025 | 353,743.00 |
| Dec 31, 2024 | 284,955.00 |
| Dec 31, 2024 | 284,955.00 |
| Sep 30, 2024 | 284,955.00 |
| Sep 30, 2024 | 284,955.00 |
| Jun 30, 2024 | 294,770.00 |
| Jun 30, 2024 | 294,770.00 |
| Mar 31, 2024 | 300,085.00 |
| Mar 31, 2024 | 300,085.00 |